Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 113.00
+1.00 (0.89%)
Jul 30, 2026, 10:02 AM CST
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 2.78 billion as of July 29, 2026. Its market cap has decreased by -32.57% in one year.
Market Cap
2.78B
Enterprise Value
2.22B
Revenue
319.67M
Ranking
n/a
PE Ratio
27.25
Stock Price
113.00
ChartMarket Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 2.78B, an increase of 88.16%. That is a compound annual growth rate of 23.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.78B | -24.32% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 6.50B |
| Hi-Clearance | 5.77B |
| WeLeader Biomedical | 3.18B |
| Applied BioCode | 3.18B |
| Wellell | 2.47B |
| A Plus Biotechnology | 2.39B |
| Medimaging Integrated Solution | 2.25B |
| OK Biotech | 2.06B |